Clinical Psychology and Psychiatry: A Closer Look

Psychiatric medications, science, marketing, psychiatry in general, and occasionally clinical psychology. Questioning the role of key opinion leaders and the use of "science" to promote commercial ends rather than the needs of people with mental health concerns.

Tuesday, January 05, 2010

Do You Have Mild, Moderate, or Severe Depression? Here, Take This Placebo, er, Antidepressant

Yet another meta-analysis with the same damn result -- antidepressants for most cases of depression are placebos. This is in a paper with a...

Wednesday, December 16, 2009

Atypical Antipsychotics For Depression: Now With "Considerable Evidence"

I've been wanting to write about this for months. Here goes. We know that antipsychotics are the new panacea for all things mental hea...

Friday, October 30, 2009

Transcranial Magnetic Stimulation for Depression: Not so Effective, but FDA Approved

Apparently, the FDA will approve just about anything as an antidepressant. Despite patients indicating that they don't perceive Abilif...

Saturday, September 19, 2009

Lend Me Your Name

Journalism regarding the horrors of ghostwritten papers in medical journals is all the rage these days ( 1 , 2 , 3 ). Here's my very sma...

Wednesday, September 09, 2009

Wanted: Drug Pimp/Key Opinion Leader

Daniel Carlat from the Carlat Psychiatry Blog received an invitation to the key opinion leader club from the good people at Schering-Plough....

Monday, August 31, 2009

Key Opinion Leader Syndrome

I ran across a rather hilarious article from Medical Hypotheses , in which David Healy described "Krapelin-Fraud Syndrome", which ...

Wednesday, July 29, 2009

The Asenapine Chronicles?

I'm not sure what to make of this. A lot of documents have become available on the Shearlings Got Plowed blog, which deal with the new...

Monday, July 20, 2009

Thanks For Your Service, Now Take This Pill

According to a freshly published study, one in five depressed patients receiving services through the VA healthcare system in the United Sta...

Wednesday, July 15, 2009

Will Pharma's (Tax) Free Speech Be Limited?

Dan Neil has an absolutely marvelous column in the LA Times about pharma's bitching/moaning regarding increased regulation of its adver...

Tuesday, July 14, 2009

Award Winning Journalism (?)

Erroneous reporting wins prestigious award, starring Charles Nemeroff. Oy. Brought to you courtesy of Health Care Renewal . Read the full ...

Friday, June 19, 2009

New American Psychiatric Association Prez: We Want Money

In a recent speech , incoming American Psychiatric Association president Alan Schatzberg was quoted as saying: "As the recent attacks o...

Friday, June 12, 2009

Greedy and Ghostly Scientists

Story one: Zachary Stowe, psychiatrist at Emory University becomes Charles Nemeroff, Jr. Read all about it the Carlat Psychiatry Blog and...

Tuesday, June 09, 2009

Abilify for Depression: Patients Give it an Oh-For-Three

Abilify for depression: you've seen the ads. You've hopefully read this blog ( 1 , 2 ) and the excellent series in the LA Times fr...

Wednesday, June 03, 2009

Pseudoscience, Candy, and Lamar Odom: Brought to you by Daniel Amen

If you follow professional basketball, you've probably noticed that LA Lakers forward Lamar Odom has a well-deserved reputation for inco...

Friday, May 22, 2009

Open Up Yer Wallets

Yeah, I know the economy is in very bad shape and possibly getting worse. But for the kind of fantastic investigative journalism we get fro...

Thursday, May 07, 2009

Phase V, Abilify, and Vanishing Akathisia

If you've been reading about Abilify for depression on this site, you've probably noticed that I've been down on Abilify for cau...

Wednesday, April 29, 2009

Abilify Runs Amok, Runs Stealth Safety Campaign in Medical Journal

Furious Seasons has a rather distressing piece of news from a recent Bristol-Myers Squibb conference call . To sum it up quickly, BMS cla...

Friday, April 17, 2009

David Healy: Marketing, Bipolar, and Biobabble

In an interview with Chrisopher Lane on Psychology Today's blog, David Healy covers the gamut, including the marketing techniques used...

Tuesday, April 14, 2009

Abilify Marketing Blitz: Atypical Antipsychotics Gone Wild

"The results are extremely unimpressive; they just squeak by," says Massachusetts psychiatrist Daniel Carlat, editor of the respec...

Friday, April 03, 2009

Leading Psychiatrist Slammed in Leading Journal

In the latest American Journal of Psychiatry appears a review of Allison Bass's book Side Effects . As many of my readers undoubtedly ...

View web version

About Me

CL Psych: I'm an academic with a respectable amount of clinical experience and no drug industry funding. Given my lack of time, don't expect multiple daily updates. Certain things about clinical psychology, the drug industry, psychiatry, and academics drive me nuts, and you'll probably pick up on these pet peeves before long...

View my complete profile

Powered by Blogger.